HCWB · HCW Biologics Inc
United States · RS rating 28 · As of 2026-11-03
| Price | 1.15 USD |
|---|---|
| 1-day change | +2.7% |
| RS rating (overall / 1M / 3M / 12M) | 28 / 12 / 5 / 12 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 27 / 54 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +49.5% |
| Sales growth Q/Q | +73.1% |
| Distance from 52-week high | +77.0% |
| Market cap (USD) | $2.8M |